These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 16933225)
1. Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: chasing windmills? Davis GL Liver Transpl; 2006 Sep; 12(9):1317-9. PubMed ID: 16933225 [No Abstract] [Full Text] [Related]
2. Monoclonal antibody HCV-AbXTL68 in patients undergoing liver transplantation for HCV: results of a phase 2 randomized study. Schiano TD; Charlton M; Younossi Z; Galun E; Pruett T; Tur-Kaspa R; Eren R; Dagan S; Graham N; Williams PV; Andrews J Liver Transpl; 2006 Sep; 12(9):1381-9. PubMed ID: 16933235 [TBL] [Abstract][Full Text] [Related]
3. Virology and pathogenesis of hepatitis C virus recurrence. Ramírez S; Pérez-Del-Pulgar S; Forns X Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723 [TBL] [Abstract][Full Text] [Related]
4. High rate of infection and immune disorders in patients with hepatitis C virus after liver transplantation. Micheloud D; Salcedo M; Bañares R; Rincón D; Jensen J; Rodríguez JJ; Fernández-Cruz E; Carbone Campoverde J; Resino S Transpl Infect Dis; 2009 Aug; 11(4):367-72. PubMed ID: 19497071 [TBL] [Abstract][Full Text] [Related]
5. Post-transplant recurrent hepatitis C: immunohistochemical detection of hepatitis C virus core antigen and possible pathogenic implications. Pessôa MG; Alves VA; Wakamatsu A; Gomes JG; Maertens G; van der Borght B; Kim M; Ferrell L; Wright TL Liver Int; 2008 Jul; 28(6):807-13. PubMed ID: 18422936 [TBL] [Abstract][Full Text] [Related]
6. Intra portal donor specific antigen transfusion might prevent re-infection of hepatitis C virus after living related liver transplantation in hepatitis C hepatic cirrhosis. Sato Y; Oya H; Yamamoto S; Kobayashi T; Watanabe T; Kokai H; Yamagiwa S; Hatakeyama K Hepatogastroenterology; 2009; 56(89):205-7. PubMed ID: 19453058 [TBL] [Abstract][Full Text] [Related]
7. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen. Jiao ZY; Jiao Z Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for hepatitis C recurrence after liver transplantation. Roche B; Samuel D J Viral Hepat; 2007 Nov; 14 Suppl 1():89-96. PubMed ID: 17958649 [TBL] [Abstract][Full Text] [Related]
9. Tissue hepatitis C virus RNA quantification and protein expression help identify early hepatitis C virus recurrence after liver transplantation. D'Errico-Grigioni A; Fiorentino M; Vasuri F; Gruppioni E; Fabbrizio B; Zucchini N; Ballardini G; Morelli C; Pinna AD; Grigioni WF Liver Transpl; 2008 Mar; 14(3):313-20. PubMed ID: 18306349 [TBL] [Abstract][Full Text] [Related]
10. Monitoring peripheral blood CD4+ adenosine triphosphate activity in a liver transplant cohort: insight into the interplay between hepatitis C virus infection and cellular immunity. Mendler M; Kwok H; Franco E; Baron P; Weissman J; Ojogho O Liver Transpl; 2008 Sep; 14(9):1313-22. PubMed ID: 18756485 [TBL] [Abstract][Full Text] [Related]
11. Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes. McCaughan GW; Shackel NA; Bertolino P; Bowen DG Transplantation; 2009 Apr; 87(8):1105-11. PubMed ID: 19384153 [TBL] [Abstract][Full Text] [Related]
12. Liver transplantation in viral hepatitis: prevention of recurrence. Roche B; Samuel D Best Pract Res Clin Gastroenterol; 2008; 22(6):1153-69. PubMed ID: 19187873 [TBL] [Abstract][Full Text] [Related]
13. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for hepatitis C recurrence in patients undergoing orthotopic liver transplantation. Sánchez-Bueno F; Ortiz ML; Bermejo J; Miras M; Pons JA; Ramírez P; Robles R; Parrilla P Transpl Immunol; 2006 Dec; 17(1):47-50. PubMed ID: 17157215 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining of liver grafts with a monoclonal antibody against HCV-Envelope 2 for recurrent hepatitis C after living donor liver transplantation. Sadamori H; Yagi T; Iwagaki H; Matsuda H; Shinoura S; Umeda Y; Ohara N; Yanai H; Ogino T; Tanaka N J Gastroenterol Hepatol; 2009 Apr; 24(4):574-80. PubMed ID: 19368635 [TBL] [Abstract][Full Text] [Related]
16. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation. Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723 [TBL] [Abstract][Full Text] [Related]
17. Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus. Bhagat V; Foont JA; Schiff ER; Regev A Liver Transpl; 2008 Jan; 14(1):92-5. PubMed ID: 18161776 [TBL] [Abstract][Full Text] [Related]